Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Clayton Utz ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Victory for transgender children in recent Family Court decision.
If parents and doctors agree, transgender children no longer need court approval before accessing hormone treatment.
Australia
13 Dec 2017
2
Not just genes: Full Federal Court upholds decision about patentability of isolated DNA
The decision provides a greater degree of certainty in relation to patentable subject matter in the field of genetics.
Australia
12 Sep 2014
3
Federal Court decides isolated DNA is patentable subject matter
The case confirms that when isolated from their natural environment, DNA sequences are patentable under Australian law.
Australia
2 Mar 2013
4
Nanotechnology - Nano Problem Or Time For Australian Business To Actively Manage Potential Risks?
While one published human study has suggested a link between certain nanoparticles and adverse health effects, prudent manufacturers and importers should identify steps to ensure that they are reasonably and effectively minimising the dangers which may be more broadly associated with nanotechnology and nanoparticles.
Australia
16 Aug 2010
5
There Was Movement At The Station: The Australian Consumer Law Reforms Are Being Enacted Into Law
Reforms are a turning point in the enforcement of Australian consumer laws. Regulators are being given increased powers and easier enforcement avenues.
Australia
13 Oct 2009
6
Labelling Of Complementary Medicines
The Trade Practices Act includes strict provisions stipulating how and when a product, including a medicinal product, can be said to be "made in Australia".
Australia
23 Sep 2007
7
The Omnitrope Experience ... Is it STOP or GO for Follow-On Biologicals in Australia?
The regulatory processes available for follow-on biologicals differ between jurisdictions; Several issues need urgent clarification for many pharmaceutical manufacturers.
Australia
15 May 2006
8
Can You Patent a Method of Medical Diagnosis or Treatment?
Methods of medical diagnosis and/or treatment have long been patentable in Australia. In Europe and New Zealand methods of medical treatment and/or diagnosis have long been excluded from patentability. However, the scope of these exclusions has recently been narrowed.
Australia
12 May 2006
9
The NHMRC Amendment Bill 2006 - Greater Autonomy and Transparency
Changes to the NHMRC will not immediately impact on those in the health and medical research sectors, but the question is whether the organisational change will percolate into that part of the Council where the Australian health industry actually has a connection?
Australia
12 May 2006
10
Spooks in the Courthouse: Third Party Access to Information in Patent Litigation
Pharmaceutical companies are becoming increasingly sophisticated in their use of publicly available records generated in litigation as a source of commercially useful information. Documentation generated in the course of legal proceedings can give rise to the potential for a third party, with no involvement in the proceedings, to obtain information about a competitor's activities which would not otherwise be available
Australia
23 Mar 2006
11
AstraZeneca Runs Out Of Puff
The "Seretide" war reached the Full Court of the Federal Court in Australia this month. The central issue in the case involved the question of whether two flyers sent to some 14,000 general practitioners in Australia and two advertisements published in "Australian Doctor" magazine relating to Glaxo's "Seretide" combination inhaler were misleading and deceptive or likely to mislead or deceive in contravention of the Australian Trade Practices Act.
Australia
23 Mar 2006
12
Patent Term Extensions for New Pharmaceutical Formulations
There is considerable debate, however, as to whether the term of formulation patents is capable of being extended in Australia.
Australia
15 Mar 2006
13
Interlocutory Injunctions for Pharmaceutical Patent Infringement
Applications for interlocutory injunctions in pharmaceutical patent infringement litigation in Australia are complicated by the need to satisfy the requirements of the Therapeutic Goods Act and to consider the role of the PBS in pharmaceutical pricing.
Australia
15 Mar 2006
14
The Australian Consumer Product Safety System - if it ainīt broke, should we fix it?
The Australian Productivity Commission has concluded that, on the whole, our current system of consumer product safety is working relatively well. There is no demonstrated economic need for any wholesale substantive reform.
Australia
13 Mar 2006
15
Patent Certification Registration/Listing Requirement to be Eased
It is expected that by April 2006, following passage of the Therapeutic Goods Amendment Bill (No.2), most complementary medicine listing applications will no longer need to include a patent certification.
Australia
 
13 Mar 2006
Links to Result pages
 
1